| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | 0.048 | 0.8 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.087 | 0.8 |